127 related articles for article (PubMed ID: 21076447)
1. Potential benefits of alkali therapy to prevent GFR loss: time for a palatable 'solution' for the management of CKD.
Sahni V; Rosa RM; Batlle D
Kidney Int; 2010 Dec; 78(11):1065-7. PubMed ID: 21076447
[TBL] [Abstract][Full Text] [Related]
2. Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet.
Wesson DE; Simoni J
Kidney Int; 2010 Dec; 78(11):1128-35. PubMed ID: 20861823
[TBL] [Abstract][Full Text] [Related]
3. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
Goraya N; Simoni J; Jo CH; Wesson DE
Kidney Int; 2014 Nov; 86(5):1031-8. PubMed ID: 24694986
[TBL] [Abstract][Full Text] [Related]
4. Does correction of metabolic acidosis slow chronic kidney disease progression?
Goraya N; Wesson DE
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):193-7. PubMed ID: 23380803
[TBL] [Abstract][Full Text] [Related]
5. Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone.
Wesson DE; Simoni J; Broglio K; Sheather S
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F830-7. PubMed ID: 21270096
[TBL] [Abstract][Full Text] [Related]
6. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
Alcázar Arroyo R
Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
[TBL] [Abstract][Full Text] [Related]
7. Acid-base status and progression of chronic kidney disease.
Goraya N; Wesson DE
Curr Opin Nephrol Hypertens; 2012 Sep; 21(5):552-6. PubMed ID: 22874469
[TBL] [Abstract][Full Text] [Related]
8. Dietary interventions to improve outcomes in chronic kidney disease.
Goraya N; Wesson DE
Curr Opin Nephrol Hypertens; 2015 Nov; 24(6):505-10. PubMed ID: 26335553
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Acidosis of CKD: An Update.
Kraut JA; Madias NE
Am J Kidney Dis; 2016 Feb; 67(2):307-17. PubMed ID: 26477665
[TBL] [Abstract][Full Text] [Related]
10. Alkali supplementation as a therapeutic in chronic kidney disease: what mediates protection?
Mannon EC; O'Connor PM
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1090-F1104. PubMed ID: 33166183
[TBL] [Abstract][Full Text] [Related]
11. Metabolic acidosis and kidney disease: does bicarbonate therapy slow the progression of CKD?
Kovesdy CP
Nephrol Dial Transplant; 2012 Aug; 27(8):3056-62. PubMed ID: 22851628
[TBL] [Abstract][Full Text] [Related]
12. Dietary Treatment of Metabolic Acidosis in Chronic Kidney Disease.
Siener R
Nutrients; 2018 Apr; 10(4):. PubMed ID: 29677110
[TBL] [Abstract][Full Text] [Related]
13. Dietary protein causes a decline in the glomerular filtration rate of the remnant kidney mediated by metabolic acidosis and endothelin receptors.
Phisitkul S; Hacker C; Simoni J; Tran RM; Wesson DE
Kidney Int; 2008 Jan; 73(2):192-9. PubMed ID: 17978813
[TBL] [Abstract][Full Text] [Related]
14. Management of the Metabolic Acidosis of Chronic Kidney Disease.
Goraya N; Wesson DE
Adv Chronic Kidney Dis; 2017 Sep; 24(5):298-304. PubMed ID: 29031356
[TBL] [Abstract][Full Text] [Related]
15. Dietary management of chronic kidney disease: protein restriction and beyond.
Goraya N; Wesson DE
Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):635-40. PubMed ID: 23079747
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.
Wesson DE; Buysse JM; Bushinsky DA
J Am Soc Nephrol; 2020 Mar; 31(3):469-482. PubMed ID: 31988269
[TBL] [Abstract][Full Text] [Related]
17. Renal acid-base titration studies in infants with and without metabolic acidosis in the postneonatal period.
Svenningsen NW
Pediatr Res; 1974 Jun; 8(6):659-72. PubMed ID: 4857677
[No Abstract] [Full Text] [Related]
18. Acidosis and progression of chronic kidney disease.
Yaqoob MM
Curr Opin Nephrol Hypertens; 2010 Sep; 19(5):489-92. PubMed ID: 20539229
[TBL] [Abstract][Full Text] [Related]
19. [End stage of chronic kidney disease and metabolic acidosis].
Klaboch J; Opatrná S; Matoušovic K; Schück O
Vnitr Lek; 2012; 58(7-8):519-24. PubMed ID: 23067161
[TBL] [Abstract][Full Text] [Related]
20. Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review.
Susantitaphong P; Sewaralthahab K; Balk EM; Jaber BL; Madias NE
Am J Nephrol; 2012; 35(6):540-7. PubMed ID: 22653322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
